Samuel Goldman, MD, MPH

Professor

VA Medicine Home

My work focuses on environmental risk factors for Parkinson’s disease and other neurodegenerative disorders. Among these are pesticides, solvents, smoking and traumatic brain injury, the microbiome, and the interaction of these factors with genetic susceptibility factors.

Education
05/1994 - Preventive Medicine, University of California-Berkeley
MPH, 05/1993 - Environmental Health Science, University of California-Berkeley
06/1988 - Internal Medicine, Mt. Zion Hospital
MD, 05/1987 - Medicine, University of Texas, Houston
BS, 08/1982 - Psychology, University of Michigan
Publications

  1. Goldman S, Aldana M, Cluzel P. Resonant learning in scale-free networks. PLoS computational biology 2023. PMID: 36809235


  2. Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR. Trichloroethylene: An Invisible Cause of Parkinson's Disease? Journal of Parkinson's disease 2023. PMID: 36938742


  3. Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. 2021. PMID: 34602502


  4. De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. 2021. PMID: 34719434


  5. Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM. Remote smartphone monitoring of Parkinson's disease and individual response to therapy. 2021. PMID: 34373643


  6. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease. 2021. PMID: 34251546


  7. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinson's disease 2021. PMID: 33649343


  8. Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. 2020. PMID: 33034846


  9. Karabayir I, Goldman SM, Pappu S, Akbilgic O. Gradient boosting for Parkinson's disease diagnosis from voice recordings. 2020. PMID: 32933493


  10. Karabayir I, Goldman SM, Pappu S, Akbilgic O. Gradient boosting for Parkinson’s disease diagnosis from voice recordings 2020. PMID:


  11. San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R, Michael J. Fox Foundation LRRK2 Cohort Consortium. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance. 2020. PMID: 32662532


  12. Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, Tanner CM, Davis RL, Goldman SM. Electrocardiographic changes predate Parkinson's disease onset. 2020. PMID: 32647196


  13. Brown EG, Goldman SM. Traumatic brain injury and α-synuclein: Proceed with caution. 2020. PMID: 31992678


  14. Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. 2020. PMID: 32925107


  15. LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM. Cervical dystonia incidence and diagnostic delay in a multiethnic population. 2019. PMID: 31774238


  16. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease. 2019. PMID: 31444591


  17. Gatz M, Plassman BL, Tanner CM, Goldman SM, Swan GE, Chanti-Ketterl M, Walters EE, Butler DA. The NAS-NRC Twin Registry and Duke Twins Study of Memory in Aging: An Update. 2019. PMID: 31354124


  18. Goldman SM, Tanner CM. Rotenone and Parkinson's Disease: Reduced Sensitivity in Females. 2019. PMID: 31161209


  19. Marras C, Canning CG, Goldman SM. Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade. 2019. PMID: 31091353


  20. Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM. Concordance for Parkinson's disease in twins: A 20-year update. 2019. PMID: 30786044


  21. Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men. International journal of epidemiology 2018. PMID: 29873737


  22. Brown EG, Goldman SM, Tanner CM. Mendel and urate: Acid test or random noise? 2018. PMID: 30100365


  23. Ethan G. Brown, Caroline M. Tanner, Samuel M. Goldman. The Microbiome in Neurodegenerative Disease. 2018. PMID:


  24. Y Leng, S M Goldman, P Cawthon, K Stone, S Ancoli-Israel, K Yaffe. 1018 Excessive Daytime Sleepiness, Objectively Measured Napping And 11-year Risk Of Parkinson’S Disease In Community-dwelling Older Men. 2018. PMID:


  25. Goldman SM, Musgrove RE, Jewell SA, Di Monte DA. Advances in Neurotoxicology. Aschner M & Costa LG, eds 2017. PMID:


  26. Ciesielska A, Samaranch L, San Sebastian W, Dickson DW, Goldman S, Forsayeth J, Bankiewicz KS. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial. 2017. PMID: 28166239


  27. Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease. 2017. PMID: 28071824


  28. Samuel M. Goldman, Ruth E. Musgrove, Sarah A. Jewell, Donato A. Di Monte. Chapter Three Pesticides and Parkinson's Disease: Current Experimental and Epidemiological Evidence. 2017. PMID:


  29. Goldman, SM, Tanner, CM. Parkinson’s Disease and Movement Disorders. Jankovic J & Tolosa E, eds 2016. PMID:


  30. Goldman SM. A diagnostic algorithm for Parkinson's disease: what next? 2015. PMID: 26271531


  31. Goldman SM, Umbach DM, Kamel F, Tanner CM. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction. 2015. PMID: 26060929


  32. Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Annals of neurology 2015. PMID: 25726936


  33. Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, Frosch MP, Ghetti B, Foroud TM, Honig LS, Marder K, Vonsattel JP, Goldman SM, Vinters HV, Ross OA, Wszolek ZK, Wang L, Dykxhoorn DM, Pericak-Vance MA, Montine TJ, Leverenz JB, Dawson TM, Vance JM. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. 2015. PMID: 25663231


  34. Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. 2015. PMID: 25401511


  35. Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. 2014. PMID: 25461423


  36. Melissa Furlong*, Caroline Tanner, Samuel Goldman, Grace Bhudhikanok, Aaron Blair, Anabel Chade, Kathleen Comyns, Monica Korell, Jane Hoppin, Meike Kasten, J William Langston, Connie Marras, Cheryl Meng, Marie Richards, G Webster Ross, David Umbach, Dale Sandler, Freya Kamel. Protective Glove Use and Workplace Hygiene Practices Modify Associations between Pesticides and Parkinson's Disease. 2014. PMID:


  37. Goldman SM, Whisnant-Cash S. Trichloroethylene: Toxicity and Health Risks 2014. PMID:


  38. Tanner CM, Goldman SM, Ross GW, Grate SJ. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. 2014. PMID: 24924672


  39. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. Peptidoglycan recognition protein genes and risk of Parkinson's disease. 2014. PMID: 24838182


  40. Samuel M. Goldman, Stephanie Whisnant Cash. Role of Trichloroethylene in Parkinson’s Disease. 2014. PMID:


  41. Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM. Dietary fat intake, pesticide use, and Parkinson's disease. 2013. PMID: 24120951


  42. Goldman SM. Environmental toxins and Parkinson's disease. 2013. PMID: 24050700


  43. Samuel M. Goldman. Parkinson's Disease. 2013. PMID:


  44. Ronald Pfeiffer, Zbigniew Wszolek, Manuchair Ebadi, Samuel Goldman. Industrial and Occupational Exposures and Parkinson Disease. 2012. PMID:


  45. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM. Genetic modification of the association of paraquat and Parkinson's disease. 2012. PMID: 23045187


  46. Samuel M. Goldman, Patricia J. Quinlan, G. Webster Ross, Connie Marras, J. William Langston, Caroline M. Tanner. Reply. 2012. PMID:


  47. S. Goldman, F. Kamel, G. Bhudhikanok, M. Korell, C. Meng, K. Comyns, D. Umbach, J. Hoppin, W. Ross, C. Marras, M. Kasten, A. Chade, D. Sandler, A. Blair, J. Langston, C. Tanner. Paraquat Use Modifies the Association of Head Injury and Parkinson's Disease (PD) (S42.003). 2012. PMID:


  48. F. Kamel, G. Richardson, D. Umbach, M. Richards, G. Bhudhikanok, A. Blair, A. Chade, K. Comyns, S. Goldman, J. Hoppin, M. Kasten, M. Korell, C. Marras, C. Meng, G. Ross, J. Langston, D. Sandler, C. Tanner. Risk of Parkinson's Disease (PD) Associated with the Herbicide Paraquat Is Attenuated by High Dietary Intake of Polyunsaturated Fatty Acids (PUFAs) (S42.004). 2012. PMID:


  49. C. Tanner, K. Albers, S. Goldman, R. Fross, A. Leimpeter, J. Klingman, S. Van Den Eeden. Seborrheic Dermatitis and Risk of Future Parkinson's Disease (PD) (S42.001). 2012. PMID:


  50. Marras C, Goldman SM. Genetics meets environment: evaluating gene-environment interactions in neurologic diseases. 2012. PMID: 22266892


  51. S.M. Goldman. 2.17.3 TRICHLOROETHYLENE (TCE) EXPOSURE AND PARKINSON'S DISEASE (PD) RISK. 2012. PMID:


  52. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, α-synuclein Rep1, and Parkinson's disease. 2012. PMID: 22275250


  53. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM. Solvent exposures and Parkinson disease risk in twins. 2011. PMID: 22083847


  54. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. 2011. PMID: 21738487


  55. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. Rotenone, paraquat, and Parkinson's disease. 2011. PMID: 21269927


  56. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. 2010. PMID: 20976736


  57. Goldman SM. Trichloroethylene and Parkinson's disease: dissolving the puzzle. 2010. PMID: 20518596


  58. S. Goldman. O.006 Epidemiology of dystonia. 2009. PMID:


  59. Freya Kamel, Grace Bhudhikanok, Aaron Blair, Samuel Goldman, Jane Hoppin, Monica Korell, J William Langston, Marie Richards, G Webster Ross, Dale Sandler, David Umbach, Caroline Tanner. Pesticide Exposure and Parkinson's Disease (PD) in the Agricultural Health Study (AHS). 2009. PMID:


  60. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. 2008. PMID: 19165397


  61. Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. 2006. PMID: 17116648


  62. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. 2006. PMID: 16718702


  63. Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Occupation and parkinsonism in three movement disorders clinics. 2005. PMID: 16162857


  64. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. Smell identification ability in twin pairs discordant for Parkinson's disease. 2005. PMID: 15719425


  65. Hollblad-Fadiman K, Goldman SM. American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis. 2003. PMID: 12657352


  66. Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, Langston JW. Smoking and Parkinson's disease in twins. 2002. PMID: 11865136


  67. Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, Langston JW, Koller WC. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. 2001. PMID: 11673577


  68. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. Parkinson disease in twins: an etiologic study. 1999. PMID: 9929087


  69. Tanner CM, Goldman SM. Epidemiology of Tourette syndrome. 1997. PMID: 9115469


  70. Zola J, Smith N, Goldman S, Woodruff BA. Attitudes and educational practices of obstetric providers regarding infant hepatitis B vaccination. 1997. PMID: 8990439


  71. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. 1996. PMID: 8827174


  72. Tanner CM, Goldman SM. Epidemiology of movement disorders. 1994. PMID: 7952243


  73. Potter WZ, Hsiao JK, Goldman SM. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. 1989. PMID: 2730280